FDA’s proposed “hub-and-spoke” drug registration rule: what it could change
FDA proposes “hub-and-spoke” networks register as one and clarifies foreign reporting; expedited updates include 5/30/120-day timelines. Comments due Sept. 11, 2026.
FDA proposes “hub-and-spoke” networks register as one and clarifies foreign reporting; expedited updates include 5/30/120-day timelines. Comments due Sept. 11, 2026.
